Breadcrumbs Navigation

Home > News & Publications > News and Communications > News

Latest Health News from Duke Medicine News and Communications

Tracking How HIV Disrupts Immune System Informs Vaccine Development

One of the main mysteries confounding development of an HIV vaccine is why some people infected with the virus make the desired antibodies after several years, but a vaccine can’t seem to induce the same response. A research team led by scientists at the Duke Human Vaccine Institute has been unraveling that mystery, detailing new insights in a study published July 29 in the journal Science Immunology.


Study Identifies Potential New Avenue for Treating Pompe Disease

Researchers at Duke Health have identified a potential new avenue for treating Pompe disease, a rare condition caused by the build-up of glycogen, a storage form of sugar, in cardiac and skeletal muscle, the liver and other tissues, due to deficiency of a particular enzyme.

Physical Declines Begin Earlier Than Expected Among U.S. Adults

Physical declines begin sooner in life than typically detected, often when people are still in their 50s, according to a Duke Health study that focused on a large group of U.S. adults across a variety of age groups.

Duke to Participate in Early Clinical Trials for Emerging Neurological Therapies

Duke University could receive up to $19 million to lead early-stage clinical trials for new drugs to treat neurological conditions such as Alzheimer’s disease and neuropathy.

Newly Described Cellular Defense Activity Could Guide Solutions to UTIs

The process cells use to secrete chemicals also appears to be the way to clear urinary tract infections, or UTIs, according to a study by researchers from Duke Health and Duke-National University of Singapore Medical School.

Moderate Exercise Might be More Effective at Combatting Pre-Diabetes

Walking briskly on a regular basis may be more effective than vigorous jogging for improving glucose control in individuals with pre-diabetes, according to research from Duke Health.

Scientists Trace Origin Cell of Bone and Soft Tissue Tumors, Test Drug Target

Scientists at Duke Health are part of a team that has discovered a type of cell surrounding blood vessels can also serve as a starting point for sarcoma, a form of cancer that occurs in bones and connective tissues.

Women with BRCA1 Gene Mutation at Higher Risk of Deadly Uterine Cancer

Women who carry the BRCA1 gene mutation that dramatically increases their risk of breast and ovarian cancers are also at higher risk for a lethal form of uterine cancer, according to a study led by a Duke Cancer Institute researcher.

Duke Scientists Identify Method of Action for Common Chemotherapy Drugs

A study by scientists at Duke Health is providing insight into how certain commonly-used chemotherapy drugs work, potentially opening new ways to enhance the benefits of treatment for cancer patients.

Duke Health Team Performs First Hand Transplant in North Carolina

A Duke Health team has performed the first hand transplant in North Carolina, attaching the limb to a 54-year-old patient from Laredo, Texas, whose hand was severed in a childhood accident.

Page of 27 Next 10 »